Podcasts about Kahn

In this bonus episode, Dr. Kahn sits down with his longtime friend TJ Robinson, founder of the Fresh Pressed Olive Oil Club and self-described "olive oil hunter." TJ has made it his life's mission to track down the freshest, highest-quality extra virgin olive oils in the world — often straight from small producers in Europe and South America — and get them shipped to the U.S. as quickly as possible. The conversation dives into what most people don't realize about olive oil: how freshness impacts flavor, health benefits, and antioxidant levels, and why the oil sitting on a grocery store shelf may not be doing your heart any favors. TJ explains how he sources each harvest, what separates truly exceptional olive oil from the rest, and why timing is everything when it comes to preserving polyphenols and taste. Dr. Kahn and TJ also discuss why extra virgin olive oil remains one of the healthiest dietary staples available, especially for cardiovascular health, and how consumers can avoid misleading labels and outdated products.  Listeners can sample the latest Fresh Pressed Olive Oil Club release for just $1 shipping by visiting getfreshDRKAHN.com .  If you prefer to watch the conversation, the full video interview is available on YouTube: youtube.com/watch?v=AZP64Au_j5M

Darren Indyke and Richard Kahn were not peripheral figures orbiting Jeffrey Epstein. They were structural supports, the load bearing pillars that allowed his criminal empire to function, survive scrutiny, and endure scandal. Darren Indyke, Epstein's longtime lawyer, was the gatekeeper. He controlled access, managed settlements, structured opaque trusts, and ensured that Epstein's money and secrets were insulated from exposure. Indyke was there through arrests, plea deals, civil suits, and reputational implosions, always positioning Epstein one legal step ahead of accountability. Without Indyke's legal architecture, Epstein's web of shell companies, offshore vehicles, and confidentiality agreements collapses under its own weight. He was not merely providing legal services. He was actively maintaining the machinery that allowed Epstein to keep operating in plain sight.And then there was Richard Kahn, the financial engineer who made the money move quietly and efficiently. Kahn handled Epstein's books, managed his finances, and kept the cash flowing through a maze designed to obscure origin, purpose, and beneficiaries. This was not passive bookkeeping. This was deliberate financial camouflage, the kind that allows illegal activity to be funded, sustained, and hidden behind layers of complexity. Together, Indyke and Kahn formed a firewall between Epstein and consequence. They didn't just serve a client, they preserved an ecosystem of abuse by protecting the money that powered it. Strip them away and Epstein is exposed, vulnerable, and limited. With them in place, he was untouchable for decades. That is what indispensability looks like, and it should haunt anyone who still pretends this was the work of a lone monster rather than a professionally maintained criminal enterprise.to contact me:bobbycapucci@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-epstein-chronicles--5003294/support.

This week, Dr. Kahn discusses a new report from the American Heart Association on the causes of heart-related deaths in the U.S., and the sobering reality that cardiovascular disease remains the nation's leading cause of death. Despite this, prevention and early detection continue to be underemphasized at the national level—meaning much of the responsibility still falls on individuals. Dr. Kahn also covers several shorter topics, including a response to the CSPI food pyramid, water quality on airplanes, Apple Watch detection of atrial fibrillation, why earlier meal timing is better, the vascular benefits of extra-virgin olive oil, and the cholesterol-lowering power of oats. Thanks to the Fresh Pressed Olive Oil Club, you can sample a bottle of high-quality extra-virgin olive oil for just $1 at getfreshDRKAHN.com. Registration is now open for Dr. Kahn's lecture on January 29, 2026 at 7:00 PM EST. Sign up HERE.

We wrap up our conversation with Niles Township Supervisor Bonnie Kahn Ognisanti. We explore her background in policy writing, what's new in Springfield, and how the community can give back.   

Are your digital ads performing poorly despite significant investment? You might be a fraud victim. This episode breaks down the explosive growth of ad fraud from $8 billion in 2015 to $140 billion today, fueled by accessible AI tools and global criminal networks. Expert Rich Kahn explains how fraudsters use bots, malware, and human click farms to steal from every digital channel. Red flags include unpredictable campaign results, chargeback spikes, and leads who don't recognize your brand. The key to fighting back is professional fraud detection using collective intelligence from multiple clients, real-time monitoring that adapts weekly, and ongoing team education. With affiliate traffic showing 45% fraud rates, waiting for a crisis costs more than proactive prevention. Free fraud scans can reveal whether your budget is bleeding money to criminals.

Dr. Williams and Dr. Kahn explore how ketogenic diets and saturated fats impact cardiovascular health and longevity. #KetogenicDiet #SaturatedFat #HeartHealth

Bots are everywhere. Yes, there are reasons to be worried. Fortunately, there are some good agents out there cracking down on the bad guys - and bringing back our confidence in media spending. In this Quick Hit, you'll hear from Rich Kahn, Co-Founder & CEO of Anura. They eliminate invalid traffic in real time - stopping bots, malware, and human fraud before they drain your budget. Catch to the full episode here

This week, Dr. Kahn dives into four new research papers on omega-3 fatty acids and their impact on heart and brain health. The discussion highlights several eye-opening findings, including reduced atrial fibrillation risk and improved cardiovascular outcomes in patients undergoing hemodialysis. Dr. Kahn also explains how omega-3 intake supports brain health and why the "right" dose depends on the specific condition being addressed. Food sources, fish oil, algae-based supplements, and ahiflower are compared as practical ways to reach optimal omega-3 levels.  Additional topics in this episode include newly approved AI software for early detection of heart disease, the role of statins in patients with type 2 diabetes, the science—and hype—around NAD+ boosters, and emerging data on Prolon fasting for Crohn's disease. Dr. Kahn also reviews concerning research on heart rhythm risks associated with high-intensity endurance exercise in athletes over the age of 50. As always, the episode blends cutting-edge research with real-world clinical insight to help clarify what actually matters for long-term heart health. Thanks to The Fresh Pressed Olive Oil Club — get a bottle for $1 at getfreshDRKAHN.com.  More About This Episode This episode takes a deeper look at why omega-3 blood levels matter more than simply taking a supplement. Dr. Kahn reviews large population studies linking higher omega-3 levels to lower risks of atrial fibrillation, early-onset dementia, and major cardiovascular events, including in high-risk groups such as patients on hemodialysis. The key takeaway: testing omega-3 status and personalizing intake may be far more effective than a one-size-fits-all approach.  Beyond omega-3s, Dr. Kahn explores several timely and surprising topics, including AI-enhanced CT scan technology designed to detect silent heart disease without additional radiation, real-world data on statin benefits in patients with type 2 diabetes, and why costly NAD+ supplements may ultimately function as a form of vitamin B3. The episode also examines new evidence on fasting-mimicking diets for Crohn's disease and potential heart rhythm risks in high-level endurance athletes over 50. Throughout the discussion, Dr. Kahn emphasizes practical, evidence-based steps patients can review with their physicians, including omega-3 blood testing, coronary calcium scoring, and tailoring lifestyle and supplement strategies to individual risk factors.

Artificial intelligence is not a substitute for human intelligence; it is a tool to amplify human creativity and ingenuity." — Fei-Fei Li Check Out These Highlights: I love this quote.  I keep hearing how AI is going to replace so many jobs, and perhaps even humans.  I personally do not agree with this mindset and think today's conversation will be relevant for leaders navigating people and technology.  Today, my guest and I are going to explore what it means to lead with a people-first mindset in a fast-moving, tech-driven world. We will discuss practical ways to strengthen human connection, build trust, and inspire innovation while fully embracing modern technology. You will walk away with a clear, accessible guide to redefining leadership where human values and digital progress work hand in hand. About Dr. Bushra Khan: Dr. Kahn is the CEO of Leading with BK, recognized for her LEAD Intelligence Framework and a signature high-energy, evidence-based facilitation style. Dr. Khan integrates over 15 years of international leadership experience with cutting-edge research, including collaborations with Daniel Goleman's team, an emotional intelligence pioneer. Top teams from organizations like Google (global Manufacturing Tech Groups in the US, Taiwan, etc.) and the Department of National Defense trust her for clarity and candor. Her mission is to dismantle the false divide between "soft skills" and business strategy, delivering practical, emotionally intelligent strategies that move people (and performance) forward.  How to Get in Touch with Dr. Bushra Khan: Websites:  http://leadingwithbk.com/ LinkedIn: https://www.linkedin.com/in/leadingwithbk/  Instagram: https://www.instagram.com/leadingwithbk Email: hello@leadingwithbk.com Stalk me online! LinkTree: https://linktr.ee/conniewhitman   Subscribe to the Enlightenment of Change podcast on your favorite podcast streaming service or YouTube.  New episodes are posted every week. Listen to Connie explore new sales and business topics or address problems you may have. 

What's up Gamers?!What happens when the digital consciousness of a machine god meets the primordial rage of a multiversal conqueror? This week on Konsole Kombat, host John is joined by a very special guest: Zach from Senjoh World! Together, they dive deep into the digital abyss to settle a battle between the two most formidable fusion villains in fighting game history.In one corner, we have the mechanical menace from Marvel vs. Capcom: Infinite: Ultron Sigma. Armed with the Reality and Space Infinity Stones, this alloyed nightmare successfully merged two realities into one and aims to convert all organic life into his mindless "Sigma Virus" drones.In the other corner, we have the embodiment of "Kombat Rage" from Mortal Kombat vs. DC Universe: Dark Kahn. Born from the accidental fusion of Darkseid and Shao Kahn, this titan of fury possesses the Omega Effect and the dark sorcery of Outworld, threatening to collapse the DC and MK universes into a singular realm of chaos.Will the "Age of Ultron Sigma" begin, or will everything succumb to the will of Dark Kahn? Tune in to find out!Don't forget to subscribe and give us your thoughts in the comments below. Get out there and level up, Kombatants!

Peptides are suddenly a buzzword in the media and amongst certain wellness-minded circles, promising to help people sleep better, look better, lose weight, gain strength, reduce inflammation, and perhaps prevent disease. But without medical-grade testing to back up these claims, are they safe to use? Dr. Amanda Kahn runs a medical practice devoted to longevity medicine and joins Martha today to break down the costs, risks and science behind the peptides and enzymes she prescribes. See omnystudio.com/listener for privacy information.

This week, Dr. Kahn breaks down the newly released USDA 2025–2030 Dietary Guidelines and the surprising upside-down food pyramid they present. He explains how the final report differs from last year's Advisory Committee recommendations, including changes in committee membership and the influence of advisors with financial ties to the meat and dairy industries. Looking back at the original 1980 dietary guidelines, Dr. Kahn asks an important question: how much has really changed? His takeaway remains refreshingly simple—eat food, mostly plants, not too much. Short topics this week include urinary measurements of protein intake, optimal timing for surgery in dilated aortic roots, the cardiovascular risk of lipoprotein(a), and whether the science behind the Blue Zones truly holds up. You can order a bottle of olive oil for just $1 at getfreshDRKAHN.com. To join the next group ProLon fast, order your kit as soon as possible at prolonlife.com/DRKAHN. If you want it a touch shorter or more punchy for Apple Podcasts specifically, I can trim it another 10–15%.

Is ad fraud secretly draining your marketing budget? Get the real story behind the billions lost, how it warps your data, and the smart moves you need to protect your brand's ROI and reputation. Don't let fake clicks steal your thunder!And don't forget! You can crush your marketing strategy with just a few minutes a week by signing up for the StrategyCast Newsletter. You'll receive weekly bursts of marketing tips, clips, resources, and a whole lot more. Visit https://strategycast.com/ for more details.==Let's Break It Down==04:58 Affiliate Marketing and Bot Fraud07:03 Detecting Fraud in Real Time11:02 "Fraud Techniques and Device Spoofing"13:49 Limitations of Basic Fraud Detection17:56 "Protecting Trust and Brand Value"20:22 "Fraud Impacts Attribution, Not Lifetime"23:31 Fraud Detection Requires Dedicated Teams29:14 The $140 Billion Fraud Problem==Where You Can Find Us==Website: https://strategycast.com/Instagram: https://www.instagram.com/strategy_cast/Facebook: https://www.facebook.com/strategycast==Leave a Review==Hey there, StrategyCast fans!If you've found our tips and tricks on marketing strategies helpful in growing your business, we'd be thrilled if you could take a moment to leave us a review on Apple Podcasts. Your feedback not only supports us but also helps others discover how they can elevate their business game!

Rich Kahn, CEO and Co-Founder of Anura, is driven by a mission to help businesses grow by eliminating digital ad fraud that silently siphons marketing budgets. A lifelong entrepreneur and developer, Rich is passionate about ensuring that advertising dollars reach real users—not bots, malware, or human fraud. We explore Rich's journey from launching an early digital advertising platform to uncovering widespread fraud that threatened his own business—and how building an internal solution eventually led to Anura. Rich breaks down his Ad Optimization Framework—Minimize Fraud, Optimize Conversion, Refresh Content—and explains why fraud must be addressed before any meaningful optimization can occur. He also shares how ad fraud impacts ROI, why lifetime value matters more than cost-per-click, and the conviction required to build and scale a SaaS company in a crowded market. — Improve Traffic Quality by 25% Overnight with Rich Kahn Good day, dear listeners. My name is Steve Preda, the Founder of the Summit OS Group, and the creator of the Summit OS Business Operating System. And today, my guest isa Rich Kahn, the CEO and Co-founder of Anura, an ad fraud solution that monitors traffic to identify real users versus bots, malware, and human fraud. Rich, welcome to the show.  Thanks for having me today.   Well, it’s super interesting business you have and the entrepreneurial journey. So let’s start with my favorite question. What is your personal ‘Why’, and how are you manifesting it in Anura?  My personal ‘Why’ has always been to help people. Fraud is a huge problem. And it’s no longer a question of if you have fraud, it’s a question of how much fraud you have. And I’m watching people spend millions and millions of dollars on digital marketing and getting it siphoned out by fraudsters with bogus traffic. So the ‘Why’ is that, in all the businesses that I've done, I've wanted to help people grow their business. I want to help people grow their staff. I wanted to help people grow, just in general.Share on X And in this case, with the Anura, I’m able to help them identify, wasted spend, eliminate that so they can grow their marketing campaigns and grow their company. And if they grow their company, then they have to grow their staff, and it’s a good thing for everybody. Yeah, definitely. And until we talked, I was not aware that fraud is rampant, especially in ad spend. It didn't occur to me. And I kind of wonder why this is happening. But tell me how you found this problem, and why do you want to solve this, and how did you get to this point to launch a company about it?  Well, in 2003, my wife and I launched a digital marketing firm. Think of Google, but really small. So it’s text-based ads you can target by keyword, bid price, geography, audience, like it had all these targeting criteria. We launched it in 2003. By 2004, we had a nice, stable list of clients, but we started getting some complaints about the traffic quality. Something wasn’t right. And I’m a developer, so I started looking at the code and realizing, looking at all the analytics and the data, and realized that it was bad traffic, it was fraudulent traffic. So I figured, you know what? I don't want to solve fraud. I want to go out, buy a fraud solution, bolt it onto my platform, and just continue doing my business.Share on X Kind of like buying McAfee for your laptop. You just buy and let it scan and do its thing. But in 2004, it didn't exist any fraud solutions. In fact, the first commercial available fraud solution didn’t start selling until 2008 or '09. So I was a developer, and I said, we're going to lose our business if I don't do something. So I figured it out I'd build it myself, and we did. I wrote the software. It worked great. We had to continue evolving it as fraud evolved. And it got to the point where we started having clients ask—if not beg—to use our software outside of our network. And that’s when we kind of got the idea that this might be a good tool to sell by itself, as opposed to baked into our platform. And that's where we launched it, in 2017. We ended up launching a Anura as a standalone solution.  Wow. I mean, it's definitely, if this is a big problem, it's going to affect everyone who advertises. So it could be hundreds of millions of people. How can someone even make money with fraudulent traffic? How does it help them to make money?   Well, what happens is internet advertising fraud is not illegal. There’s no law that says you can’t do it. So if you do find somebody that’s doing it, it’s really difficult to prosecute them in the U.S. But a lot of it happens overseas, so it’s even worse. There’s a lot of countries that allow all kinds of stuff. So basically, what we focus on is that their job is to try to make money. And I read an article one time from another company that was doing stats on fraud detection. They said the average fraudster—and this is why they do it—makes $5 million a year. But how?  There’s a lot of different ways. It depends if they're buying from Google, Facebook, DSPs, or affiliate marketing. But I’ll give you a simple example. One example, which is affiliate marketing. A lot of companies use affiliate marketing. I think it's a $20 or $30 billion industry at this point. It's a big market. So what happens is, right now, you or I can go to Amazon and sign up for their affiliate program, and every time we send them a new client, they'll give us 5% of what they spend. So I'm getting paid on the spend, right? So what if I sent fake users there? I’m not going to get paid for anything because they're not spending money. But what if I’m the fraudster? I use stolen credit cards to make those purchases. So if the purchase gets made and shipped, I get 5%. Affiliates usually get paid net 7. So I get paid net 7, somewhere across that month, maybe the next month, the person whose credit card was stolen says, “Hey, wait a second, I recognize charges that don't belong to me.” And then the investigation starts and takes months before it comes back to Amazon and says, “Oh, you shipped out a product to a fraudulent credit card. You're not getting paid for this. We're taking the money back.” But by then, they've already shipped the product, so they're out the hard cost of the product. They've already paid out the affiliate. The affiliate has already been paid. The affiliate can continue to do that for weeks, knowing that it’s going to take months for them to get caught. Once they get caught, they just set up another account. And what they're doing is making those affiliate margins. So if they spend a hundred dollars, they make five. If they create dozens and dozens of accounts, you can quickly see how they can make a lot of money in a short period of time. That’s just one example.  Yeah. That’s very interesting. Very interesting. So, okay, that’s really cool. So you basically help people not have the fake traffic. So whatever traffic they have, it’s real. So they pay real prices for real value. That’s got to be a significant improvement in advertising efficiency. What is the kind of improvement that you see on average happening for people?  On average, it’s 25% improvement. So 25% of the marketing dollars that they’re spending is fraudulent. Now, if they buy from like Google and Facebook, it's probably around 10%—they're on the lower side. If you buy from the programmatic space, like The Trade Desk and things like that, it’s upwards of 50%, and then everything else falls in between. All the digital types of marketing. If you're doing influencer advertising, if you're doing affiliate advertising, each one has different levels of fraud that we’ve found. But on the high side is programmatic, and on the low side is probably search and social.   Okay, so this seems like a big part of optimizing an ad, and making it perform better. So what I’d like you to share with us—and we'd talked about this in the pre-call is that you have a framework for generally optimizing digital ads. So what would that look like? And one element is fraud, but what are the other elements, and how do you go about optimizing your advertisement?  Sure. Like the heaviest hitter, in my opinion, is fraud. So you start with fraud, you look at where fraud is, and you minimize that, right? The next thing you want to focus on is conversion value. Every campaign has some level of conversion. It could be as simple as a click. It could be as simple as watching a video. It could be purchasing a product. It could be generating a lead for, let’s say, Hey, save money on my car insurance, and you fill out a lead. So what you want to do is look at where that conversion takes place. First off, you want to analyze the conversions because not all conversions are real conversions. You’ll get conversions like credit cards, fake credit cards being used, or fake information being used in fill in forms, and that’s where the fraud comes in. Once you eliminate that, now you can rely on the data that you see in your conversion value, and you start optimizing your campaigns around that conversion value. So as long as hey, this source is generating me a 20% conversion, this source is generating me 10%. Guess what? I want to stop spending on the 10%, spend more than the 20% just optimizing for the conversion value. And that's what's going to get your campaign to perform at its highest level.Share on X  So what are ways to optimize conversion beyond the fraud piece? Yeah, so once fraud’s out of the game, we’ve eliminated fraud, it’s really focusing on the data. What source you buy the traffic from, what sources they get the traffic from. Because sometimes you might buy a source of traffic like Google, and it may not come from Google. It may come from one of its syndicated partners like a CNN or a weather.com or Bloomberg, somewhere where you’re not familiar with, but if they’re getting traffic, that’s their partner network. They’re getting traffic from there. So you want to identify the sources. It could be by keyword, right? You can take a look and break it down by keyword. If you're looking at Google and maybe you have certain keywords that have a much higher performance because it's a better audience to targetShare on X and then you can have some that are much lower, then you got to decide what the cutoff is. So if you say, “Hey, anything less than a 10% conversion, I'm going to get rid of. And anything greater than 10%, I'm going to buy more of.” So that’s kind of where you focus on your conversion value. And ultimately, it’s to try to maximize your conversion while still spending your budget. Because let's say if you've got a source that's converting at 80%. It's going to be far and few between, and they're going to be expensive, and the volume of traffic is going to be light, and it's not going to be enough. Because if you've got one conversion a month, that's probably not enough to survive your company on. So you got to get somewhere in between, where you get the volume and you get the conversion value that you're looking for to give you the best possible campaign.Share on X So basically, you calculate your ROI on each type of conversion, and you get to a point where you still get a positive ROI. Is there like a rule of thumb? What is the kind of ROI do you need in order for it to generally be worth taking the risk of doing the advertising and putting in the effort?  Yeah. It’s very different from client to client. It’s got to be specific to a client. And I'll give you an example. I used to work with a company called TigerDirect. They were a huge reseller of electronics, computers, computer components, and stuff like that. And they would spend $110 to generate a $20 sale. So everybody knows that’s losing money, right? You're losing $80 on every sale you generate, or whatever the number is. If they're spending $100 to generate a sale just to get a $20 sale, why would they do that?  Well, they know once they get a client in the door, they market. They used to send weekly magazines of all the new stuff that's out in the market, the new pricing index, constant email bombardments. They would call you and say, “Hey, I saw you bought recordable CDs. We have a special on recordable CDs if you're looking for them.” They would market like crazy to their client base, and they would average over $300 per client.  So that’s the lifetime value.   Right. Their lifetime value was much greater than their cost for acquisition. And they were comfortable and in a position to spend that money to acquire the client knowing that they would make the money over time. Most companies don't operate that way. Most companies operate like GEICO—they pay $15 or $20 to get somebody to fill out a form saying they want to save money on car insurance. And they may close 15% of those leads into actual deals. And when they do the math, they’re making money every single lead that they get in, the ones that convert. And on the ones they lose, they're making enough money on the wins that the losses are outweighed, and they're still making money. So again, every company, every product—it's different. I've seen the same industries, like car insurance. Let's stick with car insurance. I've seen four or five companies where I'm looking at their conversion rates. Conversion rates are different. Their ROIs are different, their spend is different—everything's different. It's just targeting different audiences.Share on X  So if I had unlimited funding, let’s say, and I want to ramp up as fast as possible, but I wanted to make it in a smart way. Is there like a rule of thumb that your lifetime value—the profit you make on a customer—has to be 3x the amount you spend on advertising? And the lifetime is measured by the profit, not the top line, but the bottom line.  Yeah, I haven't seen a specific rule of thumb to give clients. Obviously, your lifetime value of a client needs to be more than the cost to acquire that client.  And if you want to be profitable, not every company starts out profitable. Look at Uber—they were a billion-dollar company before they went profitable. They were able to raise enough money to keep everything going, because all they cared about was client acquisition.  Yeah.  Let me get as many clients and as many drivers and riders in the door, as many drivers and riders in the door as they can possibly get so they can own the market. They had a great idea. Lyft was right behind them. They didn’t care. They were able to raise enough capital to just keep spending like crazy, knowing that in the long game, once they owned the market in all the different markets they were targeting, they were going to be profitable.Share on X So they were spending like crazy.  Doesn't that mean that there are some actors in the advertising market that inflate prices because maybe they’re venture-funded, and one out of a hundred company is going to make it unicorn? And the other 99 are going to be spending money on advertising, driving up prices. So if someone comes in and they're bootstrapping, they're going to be hard-pressed to actually make a return on their Facebook ads, because there's so much demand chasing results without appropriate expectation.  Well, if there’s enough demand, then the bootstrapper can make it work. I’ve been a bootstrapper my whole life. So if you’re in a market where there’s enough demand, it’ll work. But if you're in a situation where, let's say today, you decide to come up with a rideshare app, you're going to be hard-pressed to win riders and drivers as a new bootstrapped company. Personally, I don't think Uber would be where it is today if it were bootstrapped. A business model like that required to grow fast, and they needed the capital to do it. So there are certain industries that bootstrappers just aren't going to be able to touch, because you've got a company like Uber that was losing money while acquiring all these new clients, knowing that down the road they would own the network and they would be able to be profitable. That’s a big gamble. Yeah. But it's also all the other companies that get funding but never actually make it. And the venture capitalists are spreading their risk because they invest in ten companies, and if one blows up, that's enough.  Yeah.   So that means that there’s a lot of fake demand, basically.  Well, I’m talking about the demand from the client, not demand from the company. The company has the product, and they're trying to generate demand for their product. So when I say demand, I mean demand from the customer.  No, I mean, demand for advertising.  Oh, okay. Yeah, I see what you’re saying.  So clicks.   Yeah. So there's a limited number of people that are looking for that term. You’ve got a lot of people spending money. It’s going to make it difficult to get it unless you’re spending a lot per click.   Yeah.  So that means that maybe pay-per-click advertising is not for the faint of heart.  I wouldn't say that.  Yeah.   It's not for everybody when you're talking about every industry, right? Certain industries—I’ll give you an example. Let's say you're a roofer. Pay-per-click is going to work great for you because there are only so many roofers in a given area, and there's a high demand for roofing. You can get away with spending a couple dollars a click, where it’s not going to break the bank, and you get that phone ringing. My son, for example, owns a power washing and holiday lighting company. And he does Facebook and Google ads. He’s a small company, bootstrapped, and generates plenty of demand because of that situation. But again, if he decided he wanted to compete with Uber, he'd be lost. So it really depends on the industry, Insurance. Let's say you want to start your own Rich Kahn insurance company. Well, I’m going to be competing against Allstate, Progressive, GEICO—all these companies that are spending heavily in that sector. The only way you're going to get action is to spend more per click than they do. And if I’m spending more per click, and I don’t have the scale like they do, I’m going to lose money. Yeah. Super interesting. So let’s circle back to your framework. So we talked about fraud minimization as a way to optimize ads. We talked about conversion. What's the third leg of this stool?  For me, it’s content.   So let's say you've got fraud out of the game. You optimize by campaign and your ads are showing up number one every single time, but the copy doesn't draw. Or you don't refresh the copy often enough, then it gets stale, and people see it and think, “Eh, let me try somebody new.” So they're always looking for newer content, a way to hook the client. You really have to optimize campaign copy. So again, working with Google—that's ones out there—you have the ability to put up multiple ads, multiple creatives. Their system will automatically take titles and rotate them for you so they stay unique. And then they'll push more traffic to the ones that are getting a better conversion rate or a better click-through rate. So it's about constantly staying on top of your copy. Just like when you watch TV. You'll see the same companies advertising over and over again, but it's always a different commercial because they're trying to hook you. If they played the same commercial for the last 20 years, you'd just tune it out.  Tune it out. Yeah.   Yeah. But when you see something new, it's like, “Oh, let me watch that one.” It's kind of cool. Because the commercials have to have good copy. If it's boring, stale copy, nobody's going to pay attention.  And if it's entertaining, then it's even better, right?   Exactly. If it becomes memorable and you think, “Oh my God, you've got to see this commercial I just saw, it was amazing,” that's the kind of commercial you try to build—but it's very difficult to build.  Yeah, that’s very interesting. The creative element is very important. To catch attention and keep it, it has to be creative, curiosity-inducing, and potentially entertaining. That’s wonderful.  Yeah.  So when did you decide to go all in on Anura?  Yeah. We launched it April 1st, 2017. We spent that first year trying to figure out who we were as a business. Because I'd never sold SaaS before, so I was trying to figure out—do I have a pitch deck? How do I talk to people? What works best? How do I get the person to say they're interested and want to get on a call? There was so many things that we were struggling with that first year. I don’t know if we signed up more than one or two clients that first year. By the second year, we signed up a bunch of clients because we started to figure out what was working, who we’re talking to, the right trade shows to go to, the right Google ad campaigns to run.  And as we started getting that, we started getting our traction and we started growing the client base. So I guess we would say we launched in 2017, but really went all in in 2018. That's when we saw our first couple of clients jump on the software, fall in love with it, give us case studies and reviews, and say, “I can't believe how you changed my business. This is amazing.” Once we got into the hands of a client, and we had one or two clients that really embraced it, that's when we felt, “Okay, we're onto something special. We're all in.” That was about 2018.  And then you started winding down your consulting business and went all in on the SaaS business?  Yeah. We left the Google competitor, the really small Google competitor marketing agency. We left it up for a couple years because we had some clients that were still buying and using it. As the client attrition naturally occurred, we got to a point where we said, “Okay, it's time to shut it down.” That was also around 2018–2019. Basically, in 2018 we pulled all the resources from it and just kept it running for the clients that were still there. They'd been with us for years, so we kept it stable. We weren't going to trade shows, we weren't advertising it. Support was handled by two of us, the client support, actually the whole company was run by two of us, three of us, and we just let it run for a couple of years until the last client jumped off, and then we shut it down. Yeah. Actually, that's a great approach—to evolve from a business that maybe has a ceiling, find another opportunity, start putting more time into it as it takes off, reallocate resources, use the legacy business as a cash cow, your legacy business and then once the new business takes off, then basically cut bait. That’s very interesting. And I’ve seen this happen. I’ve done it myself as well. So what's the hardest decision you've ever had to make in your business?   I’m going over the last 22 years. The hardest decision I ever had to make was firing a best friend. And unfortunately, it actually happened twice. My two best friends—one was a partner and one was an employee. We were working together, and it just got to the point where we had to go our separate ways from a business standpoint, and that hurt the relationship. We stopped talking. It was a bad breakup. And I just ran into them about a year ago, and we picked up where we left off—bygones be bygones. It was tough back then because you have a good friend, and it's like, “Oh, I want to bring my friends into the business. So I always tell new business owners when they're starting: if you're going to start the business with friends as a partner, that's different.Share on X But don't hire your friends as employees. Because if you hire them as employees and you have to make a business decision that doesn't go well for them, they're going to pull the “friend card.” And you’re going to be stuck between either getting rid of a bad employee, and I say bad, but like an employee that you need to get rid of or lose a friend. That’s tough. Friends are hard to come by, especially good friends. Especially when you get older and your kids are out of school, you're not hanging out on the sidelines at sports or having coffee with people. As you get older, there are fewer groups you hang out in, so it's harder to find friends. So it’s not worth losing a friend over business.  Yeah, I agree. I agree. I had this experience as well, and it’s it was super painful for both of us. It did impact the relationship, even though we both put up a brave face over it, but it kind of breaks the trust.  Yeah. It’s not fun.   Yeah. So, final question I want to ask you is: what is the most important question an entrepreneur should ask themselves, in your opinion?  Am I willing to not give up? Like I said, when I started this company, it wasn’t a new concept. If it’s a new concept, it's a lot easier to say, “Man, I'm going to crush this.” Because when we started this, there were probably about a half a dozen different fraud solutions in the marketplace back in 2017. There was a handful of them that were out. They were already getting a lot of traction. I think all of them were fully funded and doing really well. It’s not the greatest time in the world to enter the fraud detection market when you have traction like that—kind of like entering the market trying to compete with Uber. But I looked at it and thought, based on everything I was doing, I think we have a better product. And once we started getting that feedback from clients who use the other products and realized we had a better product, it made me more convinced that this is the direction we want to go to.Share on X We want to turn this into its own company. We want to grow it. And for me, that question is: is this something I can do and not give up on? But if it’s something like you’re like, “Ah, if it doesn't do this, I don't know,” then don't start. Because one of the things you’ll find with most entrepreneurs, successful entrepreneurs, they don’t give up, persistence. They’re can be smart about it, but persistent.   It’s also a balance. It’s a belief. Maybe this is what you’re talking about that, do you have this conviction that this is going to work out in the end?  Yeah.  So how do you know? How do you know that you are willing to not give up? What makes you be able to make this decision? Is this a decision or is this like an ongoing question that you keep asking yourself?  For me, it's: I've got to run it through my head and feel that it's an unfillable business. And then I got to feel it in my heart. If I don’t feel it in my head and my heart, I’m not going to do it. I’ve had cut dozens and dozens of great ideas, some that I think would be phenomenal even in today’s standard, but I didn't have the resources I wanted behind them. I didn't really have the heart in those businesses, so I didn't start them. I wasn't all in. Like I said before, with this business, when we started it, I was all in with my toe. And then once I started getting feedback from clients, I jumped in. Because then I knew, it wasn’t me saying I’ve got the best solution, it was my client’s telling me I got a better solution. And then as I get client after client, so now you know, you look at seven, eight years later, I’ve got new people in the office. I started working for this new fraud company. I see they’re kind of small compared to some of the other big companies out in the marketplace. And then they’re on the phone with clients who are like ranting and raving about our software. They come back—now they're all in. And that's really what I want is I want every team member to feel that, to know that they're with the right company. It's not just for me—it's for the team too. Share on X Yeah, the team. I agree. That’s super important. Well, I love that. And this whole idea of the client feedback, reinforcing the value, and making people confident to sell it is huge. Yeah.  All right. So if people would like to reach out to learn about your solution—maybe they’re advertising, they’re spending a lot of money, and they want to save the 25% without losing any conversions, or they just want to reach out and learn more about and get to know you—where should they go and how can they reach you?   I would start with anura.io or www.anura.com . We own both. And on there, we have huge amount of resources. We publish several blogs every week. We have dozens of eBooks online. We have the world’s only comprehensive guide on ad fraud, it’s about an 80 page document. So plenty of ways to learn. And then once they want to talk to somebody, once they’re ready, and like they’ve done their research and they’re ready to talk to us, they can fill out a form and we'll reach out, or they can just pick up the phone and call us. If they want to follow me on LinkedIn, that’s my social media of choice. I post videos like this on there, some wacky videos sometimes with me and my grandkids. The best way to find me is just Rich Kahn on LinkedIn. I'm easy to find.   Awesome. Well, Rich, thank you for coming and sharing your framework—the Ad Optimization Framework. So it's content, fraud minimization, conversion, and this idea of conviction: when you are willing to not give up concept. It’s fabulous. For those of you listening, if you found this valuable, follow us on YouTube, check out our LinkedIn page, and stay tuned because every week we are going to get a wonderful contributor like Rich Kahn, the CEO of Anura. So Rich, thanks for coming and thanks for listening.  Appreciate it. Important Links: Rich's LinkedIn Rich's website

David L. Kahn is an author, oneironaut, and has been a member of the International Association for the Study of Dreams (IASD) since 2006.  He is a regular contributor to The Lucid Dreaming Experience magazine and has participated in several lucid dreaming research studies.  Much of his published work and many of his presentations focus on trauma dreams, particularly those of genocide survivors and LGBTQ+ youth.  He also contributed an entry to the Encyclopedia of Sleep and Dreams on dreams related to the Holocaust and the Rwandan genocides.  His books include The Oneironaut's Odyssey:  Discovering Ancient Wisdom Through Lucid Dreams and Storms and Rainbows:  Trauma Dreams of LGBTQ+ Youth. For more information about Dave and his work, please see Instagram pages: @boundless_dream @thelucidexplorer Or contact him directly at:  boundlessdreaming@gmail.com This podcast is available on your favorite platform, or here:https://endoftheroad.libsyn.com/episode-331-david-l-kahn-lucid-dreamsthe-oneironauts-odyssey-discovering-ancient-wisdom-through-lucid-dreams Have a blessed week!

durée : 00:58:47 - Les Grandes Traversées - par : Romain de Becdelièvre - Où s'arrêtent les voyages de Jef ? Sur le tard, il tombe amoureux de l'Afghanistan, qu'il célèbre en reportages, en film et dans son chef-d'œuvre : "Les Cavaliers". La steppe renoue avec la steppe et Jef refait une ultime fois le tour du monde, et du malheur. - réalisation : Julie Beressi - invités : Jean-Claude Zylberstein Éditeur; Dominique Bona Membre de l'Académie française; Gilles Heuré Journaliste et écrivain; Alfred de Montesquiou Réalisateur de documentaires; Olivier Weber Ecrivain-voyageur, grand reporter; Serge Linkès Maître de conférences à l'université de La Rochelle, chercheur à l'Institut des textes et manuscrits modernes, il a dirigé l'édition des deux tomes de Romans et récits, de Joseph Kessel, dans « La Pléiade »; Philippe Baudorre Professeur de littérature à l'université Bordeaux-3; François Heilbronn Professeur à Sciences Po et vice-président du Mémorial de la Shoah; Michèle Kahn Écrivaine et fondatrice à la SCAM du prix Joseph-Kessel; Marie-Eve Thérenty Professeure de littérature française et directrice du centre de recherche RIRRA21 à l'université de Montpellier 3.; Matthieu Letourneux Professeur de littérature à l'université Paris-Nanterre. Rédacteur en chef de Belphégor.; François Sureau Avocat, écrivain, poète, membre de l'Académie française; Marie-Astrid Charlier Maîtresse de conférence en littérature française du XIXe siècle à l'université Paul Valéry Montpellier-3

In a major development in the ongoing congressional scrutiny of the late sex-offender Jeffrey Epstein's network, the U.S. House Oversight Committee has voted to issue subpoenas to billionaire Les Wexner and two key figures tied to Epstein's financial and legal affairs, Darren Indyke and Richard Kahn. Wexner, the former head of L Brands and long-time associate of Epstein, is being asked to sit for a deposition as lawmakers press him on his longstanding ties to Epstein, including financial arrangements and the purchase of Epstein's New York home — connections that have drawn decades of public and legal attention. Indyke, Epstein's longtime lawyer, and Kahn, his in-house accountant, both co-executors of Epstein's estate, are also being subpoenaed amid allegations from survivors and committee members that they may have known about or facilitated aspects of Epstein's operations. Support for the subpoenas cut across party lines in the committee, and leaders say the actions are intended to “follow the money” and expose anyone who may have enabled or profited from Epstein's abuses.The push for these subpoenas comes amid broader pressure by Congress to uncover the full scope of Epstein's activities and connections, following the release of millions of pages of Epstein-related documents under the Epstein Files Transparency Act. Congressional leaders, particularly Rep. Robert Garcia, have framed the subpoenas as critical to delivering accountability to survivors and clarifying whether figures like Wexner, Indyke, and Kahn were aware of or complicit in Epstein's misconduct. Wexner has stated he will cooperate with inquiries but maintains he was unaware of Epstein's crimes and severed ties in the mid-2000s. Indyke and Kahn likewise deny knowledge of wrongdoing and have indicated cooperation with the investigation. The committee's actions reflect escalating legislative pressure to probe beyond the original criminal case and illuminate the financial, legal, and personal networks that supported Epstein's operations.to contact me:bobbycapucci@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-epstein-chronicles--5003294/support.

Cervical cancer is one of the most preventable cancers, and when caught early, it's often highly curable. In fact, reports say Australia is on track to eliminate cervical cancer by 2035. However, many women still have unanswered questions about symptoms, screening and what a diagnosis really means. In this Baptist HealthTalk episode, host Johanna Gomez sits down with Dr. Ryan Kahn, a gynecologic oncologist with Baptist Health Cancer Care, to answer the most searched questions women have about cervical cancer. They cover why early stages are often symptom-free, the warning signs to watch for, how survival rates change by stage and what treatment can look like (surgery, chemo, radiation and newer targeted therapies). Dr. Kahn also clears up common misconceptions about HPV, the HPV vaccine and how often you actually need a Pap/HPV test. Listen now for clear, practical guidance to help you protect your health.If you're due for screening, or noticing changes, this episode helps you know what to do next.Host:Johanna GomezAward-Winning Host & JournalistGuest:Ryan Kahn, M.D. Gynecologic OncologistBaptist Health Cancer Care

Dr. Kahn kicks off 2026 by reviewing recent media reports on aspirin use and dosing for the prevention of cardiovascular events in the President of the United States. Much of the coverage overlooks an important factor: the relationship between aspirin dose and body weight. Dr. Kahn examines data from multiple studies suggesting that, in some cases, only higher-dose aspirin was effective in preventing cardiovascular events. As always, listeners are encouraged to discuss aspirin use and dosing with their own medical team. Additional topics this week include the health impact of carryout meals, kidney function and cystatin C, statin use in patients with diabetes, the risks associated with tramadol, cold drink–induced atrial fibrillation, and recent health reports involving Chevy Chase and Jelly Roll. Dr. Kahn also invites listeners to join an upcoming group 5-day PROLON Fasting Mimicking Diet, supported by dietitians and health educators. Order your PROLON kit now at prolonlife.com/drkahn to be ready to participate.

durée : 00:58:47 - Les Grandes Traversées - par : Romain de Becdelièvre - La guerre mondiale est terminée. Mais Jef traverse encore les chaos du monde. Il assiste aux grands procès de la fin de la guerre, à la naissance de l'état d'Israël, et au début de la décolonisation du Kenya, où il rencontrera un grand fauve à crinière... - réalisation : Julie Beressi - invités : Dominique Bona Membre de l'Académie française; Alfred de Montesquiou Réalisateur de documentaires; Gilles Heuré Journaliste et écrivain; Dominique Missika Historienne, éditrice, productrice; Michèle Kahn Écrivaine et fondatrice à la SCAM du prix Joseph-Kessel; François Heilbronn Professeur à Sciences Po et vice-président du Mémorial de la Shoah; François Sureau Avocat, écrivain, poète, membre de l'Académie française; Serge Linkès Maître de conférences à l'université de La Rochelle, chercheur à l'Institut des textes et manuscrits modernes, il a dirigé l'édition des deux tomes de Romans et récits, de Joseph Kessel, dans « La Pléiade »; Matthieu Letourneux Professeur de littérature à l'université Paris-Nanterre. Rédacteur en chef de Belphégor.; Jean-Claude Zylberstein Éditeur; Pascal Génot Légataire de droit moral de Joseph Kessel et directeur SCUIOIP de l'Université de La Rochelle

Israeli billionaire and philanthropist Morris Kahn, the financial powerhouse behind Israel’s attempt to land on the moon and a range of social, medical and cultural endeavors, died Thursday at age 95. Kahn, a native of South Africa, moved to Israel in 1956. KAN's Mark Weiss spoke with journalist Steve Linde, who made aliyah from South Africa, and was a close friend of Morris Kahn. (Photo :Flash90) See omnystudio.com/listener for privacy information.

Travel is often pictured as excitement, new sights, and adventure. But for many, it can feel overwhelming, exhausting, or even impossible before a trip begins. For individuals navigating ADHD, anxiety, autism, or learning differences, the unfamiliar sounds, routines, and expectations of travel can make even the simplest journey feel heavy. And yet, these truths are rarely spoken with honesty, empathy, or care. In this deeply moving episode of Speaking of Travel, we sit down with Dr. Andrew Kahn, licensed psychologist, Associate Director at Understood.org, and a national voice on mental health and neurodiversity. Dr. Kahn brings more than 25 years of professional experience, along with his own lived experience as someone with learning and thinking differences. The result is a conversation that is both profoundly human and deeply practical, full of insight, compassion, and wisdom for travelers of all kinds. Dr. Kahn reminds us that preparation is an act of love for ourselves and for those we care about. He shares stories of patience and understanding that ripple outward, turning moments of stress into experiences of connection, growth, and joy. This conversation is an invitation to travel differently, not faster, not farther, but more gently. It's about creating space for empathy, for self-compassion, and for recognizing the courage it takes to step into the world when it feels unpredictable or challenging. Only on Speaking of Travel! Tune in. Thanks for listening to Speaking of Travel! Visit speakingoftravel.net for travel tips, travel stories, and ways you can become a more savvy traveler.

Kollel Iyun Halacha. Shuirim are held Sun-Thurs at 11 Gudz Road Lakewood NJ. For more info email: kih185miller@gmail.com

This week, Dr. Kahn shares his curated list of the top advances in heart research from 2025. He highlights key insights and perspectives from Drs. Kim Williams and Noel Merz, along with important updates from the American Heart Association. Dr. Kahn also reviews a newly published research paper on the 5-day Fasting Mimicking Diet (PROLON), including the first human evidence showing activation of autophagy. Learn what this could mean for metabolic and cardiovascular health. PROLON is available at prolonlife.com/drkahn. Thanks to tokuhealth.com/KAHN20 and their nattokinase product, Flow, for supporting the show.  Wishing everyone a healthy and happy holiday season and all the best in 2026.

durée : 00:58:46 - Les Grandes Traversées - par : Romain de Becdelièvre - Pendant l'entre-deux-guerres, Jef affine aux quatre coins du monde sa pratique du journalisme. Ses articles s'arrachent dans les kiosques, et il en prolonge l'écriture dans le roman. Mais, le climat politique s'assombrit. De nouveaux orages d'acier approchent, et Jef est aux premières loges. - réalisation : Julie Beressi - invités : Serge Linkès Maître de conférences à l'université de La Rochelle, chercheur à l'Institut des textes et manuscrits modernes, il a dirigé l'édition des deux tomes de Romans et récits, de Joseph Kessel, dans « La Pléiade »; Gilles Heuré Journaliste et écrivain; Joann Sfar Dessinateur, auteur de bandes dessinées et réalisateur; Jean-Claude Zylberstein Éditeur; Michèle Kahn Écrivaine et fondatrice à la SCAM du prix Joseph-Kessel; François Heilbronn Professeur à Sciences Po et vice-président du Mémorial de la Shoah; Marie-Eve Thérenty Professeure de littérature française et directrice du centre de recherche RIRRA21 à l'université de Montpellier 3.; Matthieu Letourneux Professeur de littérature à l'université Paris-Nanterre. Rédacteur en chef de Belphégor.; Marie-Astrid Charlier Maîtresse de conférence en littérature française du XIXe siècle à l'université Paul Valéry Montpellier-3; Olivier Weber Ecrivain-voyageur, grand reporter; Alfred de Montesquiou Réalisateur de documentaires; Dominique Missika Historienne, éditrice, productrice; François Sureau Avocat, écrivain, poète, membre de l'Académie française

Es gibt Tatsachen, die sind wie in Stein gemeißelt: Michael Jackson war der King of Pop, die beste Pizza kommt aus Italien und die geilsten Actionfilme kommen aus Hollywood … oder etwa nicht? Neben der bekannten Film-Großmacht aus L.A. hat sich ein weiteres Land zu einer echten Institution in Sachen Actionkino gemausert: Indien. Bollywood ist längst mehr als ein exotischer Trend und auch im Westen nicht mehr aus der Popkultur wegzudenken. Und wenn das indische Kino eines beherrscht, dann Popcorn-Action vom Feinsten. Um maximale Wucht auf die Leinwand zu bringen, wird nicht gekleckert, sondern geklotzt: Reisen um den halben Globus, heldenhafte Zeitlupen, extreme Nahaufnahmen, waghalsige Stunts und Explosionen, die jeder physikalischen Logik trotzen – alles ist erlaubt, solange es spektakulär ist. Doch diese Folge ist mehr als nur ein Feuerwerk aus fliegenden Fäusten und dramatischen Sprüngen. Wir sprechen auch darüber, wie das indische Kino funktioniert, welche Rolle Stars, Studios und wer der beste Kahn ist – Salman oder Shah Rukh! ---------- Kontaktseite: https://www.mdavs.de/kontakt/ Mail: MdaVs-Podcast@hotmail.com Gastbeiträge einreichen: https://www.speakpipe.com/MdaVs Podcast unterstützen: https://ko-fi.com/mdavs https://steadyhq.com/de/mdavs/about ---------- JETZT AUCH BEI DISCORD! Einladungslink für die ersten fünf Hörerinnen und Hörer: https://discord.gg/7R7vzUzRDr

This week on Heart Doc VIP, Dr. Joel Kahn takes a fresh look at niacin (vitamin B3) therapy and its role in managing cholesterol and Lipoprotein(a). He reviews both classic and recent research, explains why many clinicians have moved away from niacin, and then walks through data that suggest it may still have value when used thoughtfully and selectively. Dr. Kahn also shares a real-world case study highlighting how niacin can be effective when carefully monitored. In the episode's shorter segments, Dr. Kahn covers a wide range of timely topics, including the relationship between orange juice and heart disease, the link between uterine fibroids and cardiovascular risk, and why achieving remission from pre-diabetes matters more than ever. He also explores research on polyphenol-rich Tartary buckwheat and its potential connection to slower aging, as well as new findings on statin use and muscle strength.  As always, the episode blends evidence-based medicine with practical insights you can apply to your own heart-health journey.  Sponsor:  Thanks to koyah.com/KAHN10 — check out their excellent product line and save with the code KAHN10.

Kelsey Kahn earned her MA in Urban Planning from Hunter College and now works as a planner at FHI Studio, now IMEG. In this episode of Alumni Aloud, Idil speaks… Read the rest The post Urban Planning at FHI Studio (feat. Kelsey Kahn) appeared first on Career Planning and Professional Development.

Latorre, sobre el anuncio de Sánchez: "¿Cómo íbamos a entretenernos con el abono transporte? Si España es el Dragon Kahn"

durée : 00:58:46 - Les Grandes Traversées - par : Romain de Becdelièvre - Où commence l'aventure pour Jef ? Dans la Russie des cosaques, dans la France de la Belle époque finissante, dans un avion de la Première Guerre mondiale, dans les bars des années folles et dans un sanatorium suisse. Dès sa jeunesse, il boucle un premier tour du monde, et du malheur... - réalisation : Julie Beressi - invités : Joann Sfar Dessinateur, auteur de bandes dessinées et réalisateur; Jean-Claude Zylberstein Éditeur; Alfred de Montesquiou Réalisateur de documentaires; François Sureau Avocat, écrivain, poète, membre de l'Académie française; Marie-Eve Thérenty Professeure de littérature française et directrice du centre de recherche RIRRA21 à l'université de Montpellier 3.; Dominique Bona Membre de l'Académie française; François Heilbronn Professeur à Sciences Po et vice-président du Mémorial de la Shoah; Michèle Kahn Écrivaine et fondatrice à la SCAM du prix Joseph-Kessel; Gilles Heuré Journaliste et écrivain; Olivier Weber Ecrivain-voyageur, grand reporter; Philippe Baudorre Professeur de littérature à l'université Bordeaux-3; Serge Linkès Maître de conférences à l'université de La Rochelle, chercheur à l'Institut des textes et manuscrits modernes, il a dirigé l'édition des deux tomes de Romans et récits, de Joseph Kessel, dans « La Pléiade »; Marie-Astrid Charlier Maîtresse de conférence en littérature française du XIXe siècle à l'université Paul Valéry Montpellier-3

John Maytham speaks to Kahn Morbee, lead singer and frontman of The Parlotones, about headlining the first Get Lucky Summer show, what fans can expect from their live performance, and why this festival remains such a special part of South Africa’s summer music culture. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Darren Indyke and Richard Kahn were not peripheral figures in Jeffrey Epstein's world but central operators who helped build, maintain, and financially sustain his criminal enterprise. As Epstein's longtime lawyer and accountant, they created and managed the complex web of trusts, shell companies, bank accounts, and legal entities that allowed money to move discreetly while obscuring its purpose. Lawsuits filed by survivors and the U.S. Virgin Islands government describe them as “indispensable captains” of the enterprise, alleging they facilitated payments to victims and recruiters, structured entities to shield assets, and continued working for Epstein even after his 2008 sex-crime conviction. Though they deny any knowledge of abuse, judges have allowed civil claims against them to proceed, ruling that allegations of aiding and abetting trafficking are legally plausible and worthy of full discovery.After Epstein's death in 2019, Indyke and Kahn were named co-executors of his estate, giving them control over key documents, assets, and settlement negotiations, including a $105 million settlement with the U.S. Virgin Islands. Their continued gatekeeping role, combined with their status as beneficiaries of Epstein-linked trusts, has fueled criticism that the system has protected the very professionals accused of enabling his crimes. Despite being repeatedly named in court filings and investigative reports, they have largely avoided public scrutiny and congressional testimony. Critics argue that the failure to subpoena or question them under oath reflects a broader pattern of performative oversight, where political theater replaces substantive investigation into the financial and legal infrastructure that made Epstein's long-running operation possible.to contact me:bobbycapucci@protonmail.com

Darren Indyke and Richard Kahn were not peripheral figures in Jeffrey Epstein's world but central operators who helped build, maintain, and financially sustain his criminal enterprise. As Epstein's longtime lawyer and accountant, they created and managed the complex web of trusts, shell companies, bank accounts, and legal entities that allowed money to move discreetly while obscuring its purpose. Lawsuits filed by survivors and the U.S. Virgin Islands government describe them as “indispensable captains” of the enterprise, alleging they facilitated payments to victims and recruiters, structured entities to shield assets, and continued working for Epstein even after his 2008 sex-crime conviction. Though they deny any knowledge of abuse, judges have allowed civil claims against them to proceed, ruling that allegations of aiding and abetting trafficking are legally plausible and worthy of full discovery.After Epstein's death in 2019, Indyke and Kahn were named co-executors of his estate, giving them control over key documents, assets, and settlement negotiations, including a $105 million settlement with the U.S. Virgin Islands. Their continued gatekeeping role, combined with their status as beneficiaries of Epstein-linked trusts, has fueled criticism that the system has protected the very professionals accused of enabling his crimes. Despite being repeatedly named in court filings and investigative reports, they have largely avoided public scrutiny and congressional testimony. Critics argue that the failure to subpoena or question them under oath reflects a broader pattern of performative oversight, where political theater replaces substantive investigation into the financial and legal infrastructure that made Epstein's long-running operation possible.to contact me:bobbycapucci@protonmail.com

This week, Dr. Joel Kahn dives into a timely topic: how cold weather affects heart health. He breaks down why snow shoveling can put extra stress on the heart, what warning signs to watch for, and the simple steps anyone can take to stay safe — especially when the risks can include sudden cardiac events. He also covers a grab-bag of fascinating updates, including new insights on Lipoprotein(a) and blood type, how kimchi may support immune health, what plant-based diets mean for muscle, the link between beer bellies and heart disease, and a look at President Trump's recent heart check-up.  Special thanks to therasage.com — use code DRKAHN20 for discounts on products like the TheraPro Pad, one of Dr. Kahn's go-to wellness tools.

Eye On Research | Session 2: Adjuvant Therapies – What's New Today? (And What Can You Do About It!?) Join us for Session 2 of Eye On Research, presented by A Cure In Sight

Darren Indyke and Richard Kahn were not peripheral figures in Jeffrey Epstein's world but central operators who helped build, maintain, and financially sustain his criminal enterprise. As Epstein's longtime lawyer and accountant, they created and managed the complex web of trusts, shell companies, bank accounts, and legal entities that allowed money to move discreetly while obscuring its purpose. Lawsuits filed by survivors and the U.S. Virgin Islands government describe them as “indispensable captains” of the enterprise, alleging they facilitated payments to victims and recruiters, structured entities to shield assets, and continued working for Epstein even after his 2008 sex-crime conviction. Though they deny any knowledge of abuse, judges have allowed civil claims against them to proceed, ruling that allegations of aiding and abetting trafficking are legally plausible and worthy of full discovery.After Epstein's death in 2019, Indyke and Kahn were named co-executors of his estate, giving them control over key documents, assets, and settlement negotiations, including a $105 million settlement with the U.S. Virgin Islands. Their continued gatekeeping role, combined with their status as beneficiaries of Epstein-linked trusts, has fueled criticism that the system has protected the very professionals accused of enabling his crimes. Despite being repeatedly named in court filings and investigative reports, they have largely avoided public scrutiny and congressional testimony. Critics argue that the failure to subpoena or question them under oath reflects a broader pattern of performative oversight, where political theater replaces substantive investigation into the financial and legal infrastructure that made Epstein's long-running operation possible.to contact me:bobbycapucci@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-moscow-murders-and-more--5852883/support.

Darren Indyke and Richard Kahn were not peripheral figures in Jeffrey Epstein's world but central operators who helped build, maintain, and financially sustain his criminal enterprise. As Epstein's longtime lawyer and accountant, they created and managed the complex web of trusts, shell companies, bank accounts, and legal entities that allowed money to move discreetly while obscuring its purpose. Lawsuits filed by survivors and the U.S. Virgin Islands government describe them as “indispensable captains” of the enterprise, alleging they facilitated payments to victims and recruiters, structured entities to shield assets, and continued working for Epstein even after his 2008 sex-crime conviction. Though they deny any knowledge of abuse, judges have allowed civil claims against them to proceed, ruling that allegations of aiding and abetting trafficking are legally plausible and worthy of full discovery.After Epstein's death in 2019, Indyke and Kahn were named co-executors of his estate, giving them control over key documents, assets, and settlement negotiations, including a $105 million settlement with the U.S. Virgin Islands. Their continued gatekeeping role, combined with their status as beneficiaries of Epstein-linked trusts, has fueled criticism that the system has protected the very professionals accused of enabling his crimes. Despite being repeatedly named in court filings and investigative reports, they have largely avoided public scrutiny and congressional testimony. Critics argue that the failure to subpoena or question them under oath reflects a broader pattern of performative oversight, where political theater replaces substantive investigation into the financial and legal infrastructure that made Epstein's long-running operation possible.to contact me:bobbycapucci@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-moscow-murders-and-more--5852883/support.

Darren Indyke and Richard Kahn were not peripheral figures in Jeffrey Epstein's world but central operators who helped build, maintain, and financially sustain his criminal enterprise. As Epstein's longtime lawyer and accountant, they created and managed the complex web of trusts, shell companies, bank accounts, and legal entities that allowed money to move discreetly while obscuring its purpose. Lawsuits filed by survivors and the U.S. Virgin Islands government describe them as “indispensable captains” of the enterprise, alleging they facilitated payments to victims and recruiters, structured entities to shield assets, and continued working for Epstein even after his 2008 sex-crime conviction. Though they deny any knowledge of abuse, judges have allowed civil claims against them to proceed, ruling that allegations of aiding and abetting trafficking are legally plausible and worthy of full discovery.After Epstein's death in 2019, Indyke and Kahn were named co-executors of his estate, giving them control over key documents, assets, and settlement negotiations, including a $105 million settlement with the U.S. Virgin Islands. Their continued gatekeeping role, combined with their status as beneficiaries of Epstein-linked trusts, has fueled criticism that the system has protected the very professionals accused of enabling his crimes. Despite being repeatedly named in court filings and investigative reports, they have largely avoided public scrutiny and congressional testimony. Critics argue that the failure to subpoena or question them under oath reflects a broader pattern of performative oversight, where political theater replaces substantive investigation into the financial and legal infrastructure that made Epstein's long-running operation possible.to contact me:bobbycapucci@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-epstein-chronicles--5003294/support.

Darren Indyke and Richard Kahn were not peripheral figures in Jeffrey Epstein's world but central operators who helped build, maintain, and financially sustain his criminal enterprise. As Epstein's longtime lawyer and accountant, they created and managed the complex web of trusts, shell companies, bank accounts, and legal entities that allowed money to move discreetly while obscuring its purpose. Lawsuits filed by survivors and the U.S. Virgin Islands government describe them as “indispensable captains” of the enterprise, alleging they facilitated payments to victims and recruiters, structured entities to shield assets, and continued working for Epstein even after his 2008 sex-crime conviction. Though they deny any knowledge of abuse, judges have allowed civil claims against them to proceed, ruling that allegations of aiding and abetting trafficking are legally plausible and worthy of full discovery.After Epstein's death in 2019, Indyke and Kahn were named co-executors of his estate, giving them control over key documents, assets, and settlement negotiations, including a $105 million settlement with the U.S. Virgin Islands. Their continued gatekeeping role, combined with their status as beneficiaries of Epstein-linked trusts, has fueled criticism that the system has protected the very professionals accused of enabling his crimes. Despite being repeatedly named in court filings and investigative reports, they have largely avoided public scrutiny and congressional testimony. Critics argue that the failure to subpoena or question them under oath reflects a broader pattern of performative oversight, where political theater replaces substantive investigation into the financial and legal infrastructure that made Epstein's long-running operation possible.to contact me:bobbycapucci@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-epstein-chronicles--5003294/support.

This week, Dr. Kahn breaks down new research on erectile dysfunction (ED) as an early warning sign—a "canary in the coal mine"—for heart disease and cardiovascular events, including mortality. He also discusses the emerging role of endocrine-disrupting chemicals and highlights new findings suggesting that ED medications like Viagra and Cialis may reduce all-cause mortality and potentially lower the risk of dementia. Additional topics include the connection between sleep apnea and Parkinson's disease, how skipping breakfast may raise cholesterol levels, the impact of high-polyphenol diets on resting heart rate, tai chi for improving sleep, alternate-day fasting, updates on the Watchman device, and new approaches to treating carotid artery disease. This week, Dr. Kahn also highlights the Echo Flask—an elegant way to make hydrogen-rich water. You can order one at echowater.com for a discount.

1. Deadbeats Radio Show Intro 00:00:00 2. Casey Club - Sol 00:01:04 3. Kahn & Neek - Rally (TERMZ Bootleg) 00:04:02 4. LORE - All Night 00:06:47 5. G Jones & EPROM - Noontime Acid 00:08:23 6. Fork And Knife - Grave Rats 00:10:40 7. Levitation Jones - Optical Sliding (the apothecary remix) 00:13:24 8. G Jones & EPROM - By Your Side 00:15:48 9. MUST DIE! & Jiqui ft. JiLLi - Risk It All 00:18:26 10. Eyezic-Desire00:20:12 11. Alison Wonderland - Floating Away 00:21:35 12. Defunk-YoungandFree00:26:32 13. HDILLA-Dystopia00:29:30 14. GJones&EPROM-1000Cuts00:32:15 15. Twizzled-DevilishLaugh00:34:55 16. Ondamike-AleinRave00:36:17 17. Thrillhouseft.Benz0-Bleedin'(Nicard0Remix)00:39:15 18. GJones&EPROM-SlammingKeys00:41:03 19. longstoryshort-justBOUNCE00:42:07 20. MasQueNada-AllThatINeed00:43:46 21. HAVEN.-IRun(DJProphetEdit)00:45:13 22. CrumbPit&AmandaJoy-HeartAlreadyBroken00:46:55 23. SubFocus-Elevate00:48:20 24. Malaa(AlterEgo)-Badman00:50:21 25. Metrik-Simulation00:52:31 26. 1991-IfOnly00:55:05 27. SubFocus&Subsonic-RollTooDeep00:57:51

Former U.S. Virgin Islands Attorney General Denise George attempted to depose Jeffrey Epstein's longtime executors, Darren Indyke and Richard Kahn, as part of her civil lawsuit alleging that Epstein operated a criminal trafficking enterprise out of the USVI with the assistance of powerful financial institutions and enablers. George argued that Indyke and Kahn were more than just estate administrators—claiming they were deeply embedded within Epstein's financial and logistical operations, and therefore possessed critical knowledge regarding the movement of money, the recruitment structure, and potential co-conspirators. She sought sworn testimony that could clarify how assets were handled before and after Epstein's death, as well as whether the executors helped facilitate Epstein's access to victims or participated in concealing criminal conduct.However, her attempt ultimately fell apart when Indyke and Kahn's legal teams aggressively fought the depositions, arguing attorney-client privilege, Fifth Amendment protections, and irrelevance to the civil claims at issue. The court did not compel testimony before George was abruptly removed from her position by Governor Albert Bryan—just days after she filed a major lawsuit against JPMorgan and announced intentions to dig deeper into Epstein's financial network. Without her authority behind the push, the effort to force the executors under oath collapsed, leaving many to wonder whether political pressure and institutional fear of what they might reveal played a role in shutting the door. The result: the two people who arguably know more than almost anyone about Epstein's inner workings have never had to answer a single public question under oath about what they saw and what they did.to contact me:bobbycapucci@protonmail.com

What changes when you stop looking at someone for what they've done—and start asking who they are?Marc sits down with Diane Kahn, founder of Humans of San Quentin, who has interviewed more than 3,000 incarcerated individuals around the world. Diane shares how a single question—“How are you?”—can break open years of silence, shame, and survival.Together, they explore the unseen stories behind incarceration, why nearly everyone she meets inside was a victim first, how media narratives distort our understanding of “criminals,” and what it truly means to approach another human being with compassion. This episode challenges assumptions, expands empathy, and reveals the healing power of being seen.Timestamps:00:00 — “Who are you?”01:00 — From teacher to prison educator04:00 — The moment her perception of “prison” shattered05:45 — Who we're really locking up07:00 — Why the media is feeding us the wrong story10:00 — The power of asking: “How are you?”15:00 — Building trust inside a hyper-surveilled environment17:00 — Planting seeds of change18:00 — Lives saved through storytelling20:00 — Teaching empathy to the next generation22:00 — The big lesson: We are all kinder than we think28:00 — Holding space for thousands: Diane's mental fitness practices35:00 — The final message: vulnerability and second chances****Get your copy of Personal Socrates: Better Questions, Better Life Connect with Marc >>> Website | LinkedIn | Instagram |*A special thanks to our mental fitness + sweat partner Sip Saunas.

Former U.S. Virgin Islands Attorney General Denise George attempted to depose Jeffrey Epstein's longtime executors, Darren Indyke and Richard Kahn, as part of her civil lawsuit alleging that Epstein operated a criminal trafficking enterprise out of the USVI with the assistance of powerful financial institutions and enablers. George argued that Indyke and Kahn were more than just estate administrators—claiming they were deeply embedded within Epstein's financial and logistical operations, and therefore possessed critical knowledge regarding the movement of money, the recruitment structure, and potential co-conspirators. She sought sworn testimony that could clarify how assets were handled before and after Epstein's death, as well as whether the executors helped facilitate Epstein's access to victims or participated in concealing criminal conduct.However, her attempt ultimately fell apart when Indyke and Kahn's legal teams aggressively fought the depositions, arguing attorney-client privilege, Fifth Amendment protections, and irrelevance to the civil claims at issue. The court did not compel testimony before George was abruptly removed from her position by Governor Albert Bryan—just days after she filed a major lawsuit against JPMorgan and announced intentions to dig deeper into Epstein's financial network. Without her authority behind the push, the effort to force the executors under oath collapsed, leaving many to wonder whether political pressure and institutional fear of what they might reveal played a role in shutting the door. The result: the two people who arguably know more than almost anyone about Epstein's inner workings have never had to answer a single public question under oath about what they saw and what they did.to contact me:bobbycapucci@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-epstein-chronicles--5003294/support.

Tired of ADHD strategies that don't work? Here's what actually does. FREE training here: https://programs.tracyotsuka.com/signup_____Dr. Gilly Kahn spent years studying psychology before realizing how much of her own emotional world had been shaped by ADHD.Dr. Gilly earned a Master's in Experimental Psychology, a Ph.D. in Clinical Psychology, and built a full clinical practice before receiving her ADHD diagnosis in her early thirties. Looking back, the signs had been there all along: migraines that never made sense, intense emotional reactions, shifting hormones, and a lifelong habit of masking so well that even she missed the patterns. Like many of us, she excelled in school and in her career, which kept her symptoms invisible until they could no longer be explained away.Now based in Atlanta, Dr. Gilly specializes in neurodiversity and emotion regulation, helping women understand the parts of ADHD that rarely get named. In this conversation, she and Tracy explore why women are so often misdiagnosed, how migraines and PMDD intersect with dopamine and estrogen, and why emotional dysregulation is often the hardest part for women who appear “put together” on the outside. Dr. Gilly also breaks down the science behind sleep, memory, and hormones, and explains why trauma is often confused with ADHD in clinical settings.Her new book, Allow Me to Interrupt, brings clarity to the experiences so many women have carried silently for years and focuses on the emotional patterns that shape women's ADHD, from hormonal shifts to migraines to the pressure to stay composed even when everything feels overwhelming.Resources:LinkedIn: https://www.linkedin.com/in/gilly-kahn-m-a-ph-d-1996892b4  Instagram: https://www.instagram.com/drgillykahn Website: https://www.drgillykahn.comArticle: https://drive.google.com/file/d/1kAg0EnN_nwN1cVTM3P9cyD1wFspLg71m/view?usp=sharingSend a Message: Your Name | Email | Message If this podcast helps you understand your ADHD brain, Shift helps you train it. Practice mindset work in just 10 minutes a day. Learn more at tracyotsuka.com/shift Instead of Struggling to figure out what to do next? ADHD isn't a productivity problem. It's an identity problem. That's why most strategies don't stick—they weren't designed for how your brain actually works. Your ADHD Brain is A-OK Academy is different. It's a patented, science-backed coaching program that helps you stop fighting your brain and start building a life that fits.

Welcome back to Treknopod—we're finally out of our quarters and back on the bridge! Today we're breaking down Star Trek: Enterprise S1E8 “Breaking the Ice.” From Archer's wholesome fourth-grade Q&A to a quietly pivotal story for T'Pol, this episode nails early Vulcan–Human tension, gives Trip Tucker his most human moment yet, and even finds time for a giant space comet, a Vulcan dinner from hell with Captain Vanik, and the great starship debate: grapplers vs. tractor beams.We talk:- T'Pol's arranged-marriage dilemma and why this is a turning point for her character- Trip's confession, ethics, and the growing Enterprise “family”- Malcolm & Travis on the comet (snowman included)- Archer's leadership during awkward diplomacy- Phlox cameos, pecan pie, and the charm of early-era exploration

Wishing everyone a Happy Thanksgiving week. In this episode, Dr. Kahn breaks down the latest science on eating for longevity and overall health. He covers everything from high-protein versus plant-based diets to antioxidants, high-fat diets and Alzheimer's risk, red meat and inflammation, and how vegan diets support a lower carbon footprint. Short topics this week include new data on smoking and mortality, the link between gum disease and erectile dysfunction, and emerging research on microplastics and their potential role in atherosclerosis.  Dr. Kahn also shares insights from three recent patients at the Kahn Center.  Thank you to tryauri.com/DRKAHN for supporting the show with their high-quality mushroom gummies and elixirs.

Niles Township Supervisor Bonnie Kahn Ognisanti joins Marni and Richard to dive into the workings of a township and what services they provide. 

This week, Dr. Kahn provides details on presentations just made and published at the annual scientific meeting of the American Heart Association in New Orleans. Topics include a polypill for heart failure, coffee for atrial fibrillation, an oral PCSK9 inhibitor, beta-blockers after heart attacks, gene editing to lower cholesterol, and the use of PCSK9 inhibitors (Repatha) in a randomized trial of patients at risk for heart attack and stroke.  Dr. Kahn also reviews the role of lycopene in preventing prostate cancer (think tomatoes), colchicine in heart patients, the power of combining statins with ezetimibe, earlier mitral valve repairs, and new data suggesting that drugs like tadalafil (Cialis) may reduce the risk of death and dementia.  Dr. Kahn thanks tryauri.com/drkahn for their support and discount for listeners of Heart Doc VIP.

This week, Dr. Kahn breaks down new research presented at the American Heart Association linking melatonin use to congestive heart failure. Should you be concerned? He shares his expert perspective. Also in this episode: aspirin use in diabetes, fruit's role in Parkinson's disease, how metformin affects exercise results, the impact of heavy metals like mercury on heart health, why daily walking supports "Life's Essential 8" for Alzheimer's prevention, new CCTA data proving the benefits of statins, and how marriage might influence aging.  Don't forget to sample some high-quality olive oil at getfreshdrkahn.com.